ROADSTER IDE Study Results

Results of the ROADSTER Multicenter Trial of Transcarotid Stenting with Dynamic Flow Reversal.

Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, Macdonald S, Cambria RP.
J Vasc Surg. 2015 Nov;62(5):1227-34.

TCAR Procedure Publications

Temporary Reversal of Blood Flow During Transcarotid Artery Revascularization Does Not Change Brain Electrical Activity in Lead-In Cases of the ROADSTER 1 Multicenter Trial

Alexander H. King, MS, Raghu L. Motaganahalli, MD, Adnan Siddiqui, MD, PhD, Brian DeRubertis, MD, Wesley S. Moore, MD, Paul DiMuzio, MD, Matthew A. Eccher, MD, Vikram S. Kashyap, MD.
J Endovasc Ther. 2018 Dec;24(6), 773-778.

NESVS25. Most Patients Are Eligible for Transcarotid Revascularization Despite Its Anatomic Restrictions

Patric Liang, Winona Wu, Chun Li, Thomas F.X. O’Donnell, Nicholas J. Swerdlow, Rens R.B. Varkevisser, Mark C. Wyers, Marc L. Schermerhorn.
J Vasc Surg. 2018 Oct;68(4), e109.

TCAR (Transcarotid Artery Revascularization): The Next Step in the Evolution of Carotid Revascularization

Jeffrey Jim.
EV Today. 2018 Aug;17(8), p2S.

A Multi-Institutional Analysis of Contemporary Outcomes After Transcarotid Artery Revascularization versus Carotid Endarterectomy

Vikram S. Kashyap, Alexander H. King, Mazin I. Foteh, Jeffrey Jim, Norman H. Kumins.
J Vasc Surg. 2018 Jun;67(6), e191–e192.

In-Hospital Outcomes of Transcarotid Artery Revascularization and Carotid Endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative

Marc L. Schermerhorn, Hanaa Dakour Aridi, Vikram S. Kashyap, Grace J. Wang, Brian Nolan, Jack Cronenwett, Jens Eldrup-Jorgensen, Mahmoud B. Malas.
J Vasc Surg. 2018 Jun;67(6), e50–e51.

Postapproval Safety and Efficacy of Transcarotid Arterial Revascularization

Mark D. Balceniuk, Michael C. Stoner, Brian C. Ayers, Angela A. Kokkosis, Apostolos K. Tassiopoulos.
J Vasc Surg. 2018 Jun;67(6), e187.

The Learning Curve of Transcarotid Artery Revascularization

Alexander H. King, Mazin I. Foteh, Jeffrey Jim, Norman H. Kumins, Vikram S. Kashyap.
J Vasc Surg. 2018 Jun;67(6), e116–e117.

Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative

Mahmoud B. Malas, Hanaa Dakour-Aridi, Grace J. Wang, Vikram S. Kashyap, Raghu L. Motaganahalli, Jens Eldrup-Jorgensen, Jack L. Cronenwett, Marc L. Schermerhorn.
J Vasc Surg. 2018 Jun;67(6), e170-e171.

One-Year Results of the ROADSTER Multicenter Trial of Transcarotid Stenting With Dynamic Flow Reversal

Mahmoud Malas, Besma J. Nejim, Christopher J. Kwolek, Jose Ignacio Leal Lorenzo, Tod Hanover, Manish Mehta, Vikram S. Kashyap, Richard Cambria.
J Vasc Surg. 2017 Jan;67(1), e5.

Pre- and Post-Transcarotid Artery Revascularization Characteristics of Common Carotid Artery: A Post Hoc Analysis of ROADSTER-1 Trial

Raghu L. Motaganahalli, Michael Jaff, Christopher J. Kwoleck, Sumaira MacDonald, Richard Rudey, Richard P. Cambria.
J Vasc Surg. 2017 Aug;66(2), e34–e35.

Transcarotid Artery Revascularization With Flow Reversal*

Alpaslan A, Wintermark M, Pintér L, Macdonald S, Ruedy R, Kolvenbach R.
J Endovasc Ther. 2017 Apr;24(2):265-270.

Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system

Malas MB, Leal J, Kashyap V, Cambria RP, Kwolek CJ, Criado E.
J Vasc Surg. 2017 Mar;65(3):916-920.

The ROADSTER Investigational Device Exemption Trial Leads to Food and Drug Administration Approval of the First Stent Labeled for Trans-Carotid Artery Revascularization

Manish Mehta, Vikran Kashyap, Mahmoud Malas, Philip Paty, Richard Cambria, Christopher Kwolek, Rasesh Shah, Enrique Criado, and others.
J Vasc Surg. 2016 Sept;64(3), p841–842

Transcarotid Artery Revascularization With High-Rate Flow Reversal Embolic Protection Demonstrates Improved Stroke and Death Rate Following FDA Premarket Clearance

Christopher J. Kwolek, Glenn M. LaMuraglia, Richard P. Cambria.
J Vasc Surg. 2016 Jun;63(6), p4S.

1-Year Follow-up After Transcarotid Artery Revascularization (TCAR) With Enroute Transcarotid Neuroprotection System

Ignacio Leal, Javier Peinado, Maria Lamarca, Ricardo Montoya, Angel Flores, Antonio Orgaz, Manuel Doblas, Enrique Criado
J Vasc Surg. 2016 Jun;63(6), p14S

Transcervical Carotid Stenting With Dynamic Flow Reversal Demonstrates Embolization Rates Comparable to Carotid Endarterectomy*

Plessers M, Van Herzeele I, Hemelsoet D, Patel N, Chung EM, Vingerhoets G, Vermassen F.
J Endovasc Ther. 2016 Apr;23(2):249-54.

New technologies for CAS that might overcome the burden of microembolization.

Yamada R1, Guimaraes M, Adams J, Schönholz C.
J Cardiovasc Surg (Torino). 2015 Dec;56(6):859-65.

First clinical use of a novel neurovascular access and neuroprotection system demonstrates complete absence of emboli by transcranial Doppler during carotid artery stenting.*

Pinter L, Ribo M, Roberts T, Chou TM, Kolvenbach RR.
J Cardiovasc Surg (Torino). 2011 Dec:52(6):853-7.

* The ENROUTE NPS and Stent Systems are approved for use in the EU in patients at standard risk for complications from CEA. These indications have not been evaluated by the US FDA.
The links on this page take you away from the Silk Road Medical website. These websites are not operated by Silk Road Medical. Silk Road Medical does not control the content of these websites.